Patents Assigned to Veritron Limited
  • Publication number: 20140023736
    Abstract: A composition comprising an aqueous extract of camomile flowers is useful for the treatment of a proliferative and/or inflammatory condition.
    Type: Application
    Filed: September 25, 2013
    Publication date: January 23, 2014
    Applicants: Veritron Limited, Insignion Holdings Limited
    Inventor: Matthias Heinrich Kreuter
  • Patent number: 8591966
    Abstract: A composition comprising an aqueous extract of camomile flowers is useful for the treatment of a proliferative and/or inflammatory condition.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: November 26, 2013
    Assignees: Insignion Holdings Limited, Veritron Limited
    Inventor: Matthias Heinrich Kreuter
  • Publication number: 20100178368
    Abstract: A composition comprising an aqueous extract of camomile flowers is useful for the treatment of a proliferative and/or inflammatory condition.
    Type: Application
    Filed: June 2, 2008
    Publication date: July 15, 2010
    Applicants: INSIGNION HOLDINGS LIMITED, VERITRON LIMITED
    Inventor: Matthias Heinrich Kreuter
  • Publication number: 20090285921
    Abstract: The present invention is directed to a composition comprising an aqueous extract of camomile flowers for the treatment of a proliferative and/or viral condition.
    Type: Application
    Filed: December 1, 2008
    Publication date: November 19, 2009
    Applicant: Veritron Limited
    Inventor: Matthias-Heinrich Kreuter
  • Publication number: 20090175970
    Abstract: A plant extract, obtainable by aqueous extraction, is stabilised by the presence of a water-soluble agent capable of chelating the extract or a component thereof.
    Type: Application
    Filed: March 12, 2009
    Publication date: July 9, 2009
    Applicant: VERITRON LIMITED
    Inventor: Klaus Diergarten
  • Publication number: 20090169659
    Abstract: A process for purifying an aqueous composition including a water-soluble contaminant having lipid groups, e.g. an endotoxin, comprises contacting the composition with a lipophilic component that forms a complex with the contaminant; a first removal step, of material having a size larger than the complex; and a second removal step, of the complex.
    Type: Application
    Filed: November 14, 2006
    Publication date: July 2, 2009
    Applicant: VERITRON LIMITED
    Inventor: Mathias-Heinrich Kreuter
  • Patent number: 7115563
    Abstract: A composition having a variety of therapeutic and cosmetic uses comprises: (i) a vitamin; (ii) a metal salt that provides metal ions in vivo; and (iii) insulin or a growth hormone. Such a composition is useful for treating, for example, genetic disorders, skin diseases, cancer and viral infections.
    Type: Grant
    Filed: May 29, 2003
    Date of Patent: October 3, 2006
    Assignees: Insignion Holding Limited, Veritron Limited
    Inventors: Rafeda M. A. Younis, Karam M. H. Al Sari, Saad M. H. Al Sari, Ahmad M. H. Al Sari